Treatment outcomes of a combination with intensity-modulated radiotherapy and three fractions of computed tomography-guided brachytherapy for uterine cervical cancer: A single-institution analysis in Japan
This single-institution retrospective study demonstrates that combining intensity-modulated radiotherapy with a reduced three-fraction CT-guided brachytherapy regimen for uterine cervical cancer achieves excellent local control and acceptable toxicity, offering a practical approach to minimize patient burden while highlighting the need for intensified treatment in advanced-stage cases.
Original paper licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). This is an AI-generated explanation of the paper below. It is not written or endorsed by the authors. For technical accuracy, refer to the original paper. Read full disclaimer
Cancer of the cervix, the lower part of the uterus that connects to the vagina, remains a significant health challenge worldwide. For many years, the standard treatment for this disease has been a combination of two types of radiation therapy. The first is external beam radiation, where a machine outside the body aims high-energy beams at the entire pelvic area to kill cancer cells and shrink tumors. The second is brachytherapy, a more targeted approach where a radioactive source is placed directly inside the body, close to the tumor, to deliver a powerful dose of radiation exactly where it is needed. While this combination is highly effective, the process can be physically demanding and emotionally draining for patients, often requiring multiple hospital visits over several weeks. In recent years, medical technology has advanced to allow for more precise shaping of radiation beams, known as intensity-modulated radiation therapy, which can spare healthy tissue better than older methods. However, the question remains whether these modern techniques can maintain high success rates while reducing the number of treatment sessions required for the internal radiation, thereby lessening the burden on the patient.
Researchers at Tohoku University in Japan set out to investigate a specific treatment plan that combines these modern external beams with a shortened schedule for the internal radiation. They looked back at the medical records of 92 women treated between 2017 and 2023 for cervical cancer. These patients received a course of external radiation to the whole pelvis, followed by a reduced series of just three sessions of internal radiation, guided by computed tomography scans. The goal was to see if this streamlined approach could still control the cancer effectively without causing severe side effects. The study focused on whether the cancer returned in the pelvic area, how long patients remained free of the disease, and how long they survived, while also carefully monitoring for any serious long-term harm to nearby organs like the bladder and rectum.
The results of this analysis were encouraging. Over a median follow-up period of roughly three and a half years, the treatment proved highly successful at keeping the cancer from returning in its original location. Specifically, 94.5 percent of the patients remained free of local recurrence three years after starting treatment. The overall survival rate was also strong, with 86.2 percent of patients alive three years after treatment began. The researchers found that the size of the tumor at the start of treatment was a key factor in the outcome; patients with smaller tumors had better results than those with larger, more advanced disease. While the treatment was generally well-tolerated, there were a few instances of severe side effects. Four patients experienced serious late complications, such as severe inflammation of the rectum or bleeding from the bladder, which required significant medical intervention. One patient unfortunately passed away due to complications related to bladder bleeding, but for the vast majority, the treatment was safe and effective.
The study suggests that using advanced external radiation combined with a shortened, three-session internal radiation schedule is a viable and practical option for treating cervical cancer. This approach appears to offer a good balance between fighting the disease aggressively and reducing the physical and psychological toll on the patient. The researchers noted that while the results were excellent for most, patients with more advanced stages of the disease might still benefit from more intensive treatment strategies. By confirming that fewer internal radiation sessions can yield strong results, this work offers a potential path forward to make cancer care more manageable for patients without sacrificing the quality of their survival. The findings support the idea that modern, precise radiation techniques can be adapted to fit the needs of patients, making a difficult journey through treatment slightly less burdensome.
Drowning in papers in your field?
Get daily digests of the most novel papers matching your research keywords — with technical summaries, in your language.